Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cho-Hung Chiang

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|December 22, 2024
Glucagon-like Peptide-1 Agonists Reduce Cardiovascular Events in Cancer Patients on Immune Checkpoint InhibitorsCho-Han Chiang, Junmin Song, Kuan-Yu Chi, et al.
Gastroenterology|June 11, 2025
Glucagon-like peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: a Systematic Review and Meta-analysisCho-Hung Chiang, Aunchalee Jaroenlapnopparat, Sena Cakir Colak, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2023
Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort studyCho-Han Chiang, Yuan-Jen Chen, Cho-Hsien Chiang, et al.
BMJ Open Respiratory Research|January 23, 2024
Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysisXin Ya See, Tsu Hsien Wang, Yu-Cheng Chang, et al.
Blood Advances|February 5, 2025
Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulationCho-Han Chiang, Junmin Song, Yu-Cheng Chang, et al.
Japanese Journal of Clinical Oncology|October 8, 2022
The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populationsCho-Han Chiang, Cho-Hung Chiang, Kevin Sheng-Kai Ma, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2025
Glucagon-like peptide 1 receptor agonists and risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trialsCho-Han Chiang, Yu-Cheng Chang, Chun-Chiao Yu, et al.
Annals of Internal Medicine|December 8, 2025
Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-analysisAlbert Ko, Yu-Cheng Chang, Furkan Bahar, et al.
Journal of Gastroenterology and Hepatology|January 31, 2024
The impact of sodium-glucose cotransporter-2 inhibitors on outcome of patients with diabetes mellitus and colorectal cancerCho-Han Chiang, Cho-Hung Chiang, Yuan Ping Hsia, et al.
European Journal of Cancer (Oxford, England : 1990)|August 14, 2022
Efficacy of cationic amphiphilic antihistamines on outcomes of patients treated with immune checkpoint inhibitorsCho-Han Chiang, Cho-Hung Chiang, Chun-Yu Peng, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|December 22, 2024
Glucagon-like Peptide-1 Agonists Reduce Cardiovascular Events in Cancer Patients on Immune Checkpoint InhibitorsCho-Han Chiang, Junmin Song, Kuan-Yu Chi, et al.
Gastroenterology|June 11, 2025
Glucagon-like peptide-1 Receptor Agonists and Gastrointestinal Adverse Events: a Systematic Review and Meta-analysisCho-Hung Chiang, Aunchalee Jaroenlapnopparat, Sena Cakir Colak, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2023
Effect of metformin on outcomes of patients treated with immune checkpoint inhibitors: a retrospective cohort studyCho-Han Chiang, Yuan-Jen Chen, Cho-Hsien Chiang, et al.
BMJ Open Respiratory Research|January 23, 2024
Impact of different corticosteroids on severe community-acquired pneumonia: a systematic review and meta-analysisXin Ya See, Tsu Hsien Wang, Yu-Cheng Chang, et al.
Blood Advances|February 5, 2025
Glucagon-like peptide 1 receptor agonists and venous thromboembolism in type 2 diabetes: a target trial emulationCho-Han Chiang, Junmin Song, Yu-Cheng Chang, et al.
Japanese Journal of Clinical Oncology|October 8, 2022
The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populationsCho-Han Chiang, Cho-Hung Chiang, Kevin Sheng-Kai Ma, et al.
Journal of Thrombosis and Haemostasis : JTH|July 2, 2025
Glucagon-like peptide 1 receptor agonists and risk of venous thromboembolism: a systematic review and meta-analysis of randomized controlled trialsCho-Han Chiang, Yu-Cheng Chang, Chun-Chiao Yu, et al.
Annals of Internal Medicine|December 8, 2025
Risk for Cancer With Glucagon-Like Peptide-1 Receptor Agonists and Dual Agonists : A Systematic Review and Meta-analysisAlbert Ko, Yu-Cheng Chang, Furkan Bahar, et al.
Journal of Gastroenterology and Hepatology|January 31, 2024
The impact of sodium-glucose cotransporter-2 inhibitors on outcome of patients with diabetes mellitus and colorectal cancerCho-Han Chiang, Cho-Hung Chiang, Yuan Ping Hsia, et al.
European Journal of Cancer (Oxford, England : 1990)|August 14, 2022
Efficacy of cationic amphiphilic antihistamines on outcomes of patients treated with immune checkpoint inhibitorsCho-Han Chiang, Cho-Hung Chiang, Chun-Yu Peng, et al.
Pageof 6